Evaluating the association of HSV2 infection in HIV progression in HIV positive patients.
Phase 1
- Conditions
- HIV AIDS.Human immunodeficiency virus [HIV]
- Registration Number
- IRCT201311094076N12
- Lead Sponsor
- Resaerch Deputy tehran university of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 180
Inclusion Criteria
Inclusion criterion: HIV positive patients referred to Iranian Research Center for HIV/AIDS-Imam Khomeini Hospital with CD4 count of 400-900 cells/mm3 and not being under antiviral therapy.
Exclusion criteria: CD4 count above 400-900 cells/mm3; co infected with either HBV or HCV; having genital wart.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method CD4 Count. Timepoint: 1 year after intervention and starting for treatment. Method of measurement: Blood Test.;Viral Load. Timepoint: 1 year after intervention and starting for treatment. Method of measurement: Blood Test.
- Secondary Outcome Measures
Name Time Method HIV progression. Timepoint: 1 year after starting the project. Method of measurement: lab tests and physical exams.